The table below shows Burning Rock Biotech Ltd's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$77.16M
$70.67M
$75.70M
$81.66M
$79.69M
$65.89M
Cost of revenue
$19.54M
$21.02M
$24.54M
$26.56M
$22.55M
$17.77M
Gross profit
$57.62M
$49.65M
$51.16M
$55.10M
$57.14M
$48.11M
R&D
$23.81M
$31.82M
$48.88M
$61.16M
$57.73M
$40.45M
BNR annual revenue (10-K history)
Burning Rock Biotech Ltd reported annual revenue of $77.16M for fiscal year 2025. That is up 9.2% from $70.67M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $65.89M (FY 2020) to $77.16M. Figures come from the company's audited annual reports as filed with the SEC.